RC
GILD icon

Randolph Company’s Gilead Sciences GILD Stock Holding History

Randolph Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,216
Closed -$512K – 37
2015
Q3 		$512K Buy
+5,216
New +$579K 0.12% 39
2014
Q1 		– Sell
-123,664
Closed -$9.29M – 40
2013
Q4 		$9.29M Hold
123,664
– – 1.84% 25
2013
Q3 		$7.78M Hold
123,664
– – 1.74% 23
2013
Q2 		$6.34M Buy
+123,664
New +$6.45M 1.39% 21

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Randolph Company's GILD Position: Q4 2015 in Review

Randolph Company sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 5,216 shares — an estimated $512K sold.

Randolph Company first reported a position in GILD in Q2 2013 and held it in 4 quarters. The position peaked at $9.29M in Q4 2013. 1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Randolph Company reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
  • Randolph Company sold 5,216 Gilead Sciences shares in Q4 2015, an estimated $512K.
  • Randolph Company first reported a position in Gilead Sciences in Q2 2013 and held it in 4 quarters.
  • Randolph Company's Gilead Sciences position peaked at $9.29M in Q4 2013.
  • 1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Randolph Company's 13F filing for Q4 2015, filed 19 Jan 2016.